Compare KeyCorp (KEY) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KeyCorp vs 10X Genomics Inc — how do they compare? KeyCorp trades at $22.7 (market cap $24.32B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: KeyCorp is far larger — about 3.2× 10X Genomics Inc's market cap, and KeyCorp pays a 3.61% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| KEY | TXG | |
|---|---|---|
Market Cap | $24.32B | $7.61B |
Sector | Financials | Health |
52-Week High | $23.99 | $58.57 |
52-Week Low | $16.78 | $11.34 |
Dividend Yield | 3.61% | — |
Enterprise Value | — | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
